Literature DB >> 27818212

The human papillomavirus E7 oncoprotein as a regulator of transcription.

William K Songock1, Seong-Man Kim1, Jason M Bodily2.   

Abstract

High-risk human papillomaviruses (HPVs) encode oncoproteins which manipulate gene expression patterns in the host keratinocytes to facilitate viral replication, regulate viral transcription, and promote immune evasion and persistence. In some cases, oncoprotein-induced changes in host cell behavior can cause progression to cancer, but a complete picture of the functions of the viral oncoproteins in the productive HPV life cycle remains elusive. E7 is the HPV-encoded factor most responsible for maintaining cell cycle competence in differentiating keratinocytes. Through interactions with dozens of host factors, E7 has an enormous impact on host gene expression patterns. In this review, we will examine the role of E7 specifically as a regulator of transcription. We will discuss mechanisms of regulation of cell cycle-related genes by E7 as well as genes involved in immune regulation, growth factor signaling, DNA damage responses, microRNAs, and others pathways. We will also discuss some unanswered questions about how transcriptional regulation by E7 impacts the biology of HPV in both benign and malignant conditions.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell cycle control; E7; Histone deacetylase; Innate immunity; Transcription factor; pRb family

Mesh:

Substances:

Year:  2016        PMID: 27818212      PMCID: PMC5325776          DOI: 10.1016/j.virusres.2016.10.017

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  365 in total

Review 1.  RB gene family: genome-wide ChIP approaches could open undiscovered roads.

Authors:  Flavio Rizzolio; Luca Esposito; Debora Muresu; Robert Fratamico; Ranna Jaraha; Gianluca Vosa Caprioli; Antonio Giordano
Journal:  J Cell Biochem       Date:  2010-04-01       Impact factor: 4.429

2.  High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.

Authors:  Jeanette Reiser; José Hurst; Maike Voges; Peter Krauss; Peter Münch; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

3.  RNA interference of human papillomavirus type 16 E7 increases HLA class I antigen expression in HaCaT-E7 cells.

Authors:  Xiao-Mei Deng; Wei Li; Xiao Zhang; Chuan-Xin Wang; Zhao-Gang Dong; Xin Zhang; Gui-Xi Zheng; Xu-Hua Zhang; Ni Zheng; Li-Li Wang; Lu-Tao Du; Shun Wang
Journal:  Int J Gynecol Cancer       Date:  2011-01       Impact factor: 3.437

4.  The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.

Authors:  E R Flores; B L Allen-Hoffmann; D Lee; P F Lambert
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Down-regulation of HLA class I antigen in human papillomavirus type 16 E7 expressing HaCaT cells: correlate with TAP-1 expression.

Authors:  Wei Li; Xiao-Mei Deng; Chuan-Xin Wang; Xiao Zhang; Gui-Xi Zheng; Jian Zhang; Jin-Bo Feng
Journal:  Int J Gynecol Cancer       Date:  2010-02       Impact factor: 3.437

6.  Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines.

Authors:  Margaret E McLaughlin-Drubin; Donglim Park; Karl Munger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-17       Impact factor: 11.205

7.  Human papillomavirus type 16 E7 oncoprotein associates with E2F6.

Authors:  Margaret E McLaughlin-Drubin; Kyung-Won Huh; Karl Münger
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

8.  Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.

Authors:  Jasper Manning; Marie Indrova; Barbora Lubyova; Hana Pribylova; Jana Bieblova; Jiri Hejnar; Jana Simova; Tana Jandlova; Jan Bubenik; Milan Reinis
Journal:  Immunology       Date:  2007-08-28       Impact factor: 7.397

9.  The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.

Authors:  M S Barbosa; C Edmonds; C Fisher; J T Schiller; D R Lowy; K H Vousden
Journal:  EMBO J       Date:  1990-01       Impact factor: 11.598

10.  Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes.

Authors:  Kathryn H Richards; Rosella Doble; Christopher W Wasson; Mohammed Haider; G Eric Blair; Miriam Wittmann; Andrew Macdonald
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

View more
  35 in total

1.  Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle.

Authors:  Michael R Evans; Claire D James; Molly L Bristol; Tara J Nulton; Xu Wang; Namsimar Kaur; Elizabeth A White; Brad Windle; Iain M Morgan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Attenuation of Equine Lentivirus Alters Mitochondrial Protein Expression Profile from Inflammation to Apoptosis.

Authors:  Cheng Du; Yingyi Duan; Xue-Feng Wang; Yuezhi Lin; Lei Na; Xinhui Wang; Kewei Chen; Xiaojun Wang
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

3.  Characterization of the High-Affinity Fuzzy Complex between the Disordered Domain of the E7 Oncoprotein from High-Risk HPV and the TAZ2 Domain of CBP.

Authors:  Michael W Risør; Ariane L Jansma; Natasha Medici; Brittany Thomas; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2021-12-14       Impact factor: 3.162

4.  Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1.

Authors:  Hye Hwa Lee; Seol Hee Hong; Joon Haeng Rhee; Shee Eun Lee
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

5.  Genome-Wide Transcriptome Analysis of Human Papillomavirus 16-Infected Primary Keratinocytes Reveals Subtle Perturbations Mostly due to E7 Protein Expression.

Authors:  Malgorzata Bienkowska-Haba; Wioleta Luszczek; Katarzyna Zwolinska; Rona S Scott; Martin Sapp
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

6.  Suppression of MicroRNA 424 Levels by Human Papillomaviruses Is Necessary for Differentiation-Dependent Genome Amplification.

Authors:  Shiyuan Hong; Shouqiang Cheng; William Songock; Jason Bodily; Laimonis A Laimins
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

Review 7.  Virus against virus: strategies for using adenovirus vectors in the treatment of HPV-induced cervical cancer.

Authors:  Momeneh Ghanaat; Nasser Hashemi Goradel; Arash Arashkia; Nasim Ebrahimi; Sajjad Ghorghanlu; Ziba Veisi Malekshahi; Esmail Fattahi; Babak Negahdari; Hami Kaboosi
Journal:  Acta Pharmacol Sin       Date:  2021-02-25       Impact factor: 6.150

8.  Human papillomavirus, gene mutation and estrogen and progesterone receptors in breast cancer: a cross-sectional study.

Authors:  Abdallah Mohammed Elagali; Ahmed Abdelbadie Suliman; Mohammed Altayeb; Anas Ibrahim Dannoun; Narasimha Reddy Parine; Hader Ibrahim Sakr; Howayda Saeed Suliman; Moustafa Elsaeid Motawee
Journal:  Pan Afr Med J       Date:  2021-01-15

9.  Cdc6 contributes to abrogating the G1 checkpoint under hypoxic conditions in HPV E7 expressing cells.

Authors:  Hanxiang Chen; Qishu Zhang; Lijun Qiao; Xueli Fan; Weifang Zhang; Weiming Zhao; Jason J Chen
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

10.  Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway.

Authors:  Martin Fischer; Sigrid Uxa; Clara Stanko; Thomas M Magin; Kurt Engeland
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.